After experiencing small molecules and biopharmaceuticals, in recent years, cell and gene therapies have started to become a reality, with innovative emerging therapies changing the way we study and treat human diseases.

Cell and gene therapy provide new methods for Cancer and immune system diseases. The commercialization of cell therapy relies on the optimization of upstream process development, testing, and downstream production. Gene therapy requires the development of reliable and scalable processes to produce plasmids and viral vectors.

Therefore, biopharmaceutical manufacturers require their partners to have extensive experience in the process development, scale-up, and production of cell and gene therapy products, and to guarantee regulatory compliance.

With a wealth of expertise, technology and services, Cobetter provides solutions for filtration and purification, as well as single-use systems in virus vectors, plasmids, and LNP production.